| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |